Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
39
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Case report of a KIT-mutated melanoma patient with an excellent response to apatinib and temozolomide combination therapy

Cong Luo1 Department of Abdominal Oncology, Zhejiang Cancer HospitalCorrespondence[email protected]
,
Jiayu Shen2 The Second Clinical Medical College, Zhejiang Chinese Medical University
,
Jieer Ying1 Department of Abdominal Oncology, Zhejiang Cancer Hospital
,
Xianhua Fang3 Department of Pathology
,
Xiaohong Wang1 Department of Abdominal Oncology, Zhejiang Cancer Hospital
,
Zhixuan Fu4 Department of Colorectal Surgery
&
Peng Liu5 Department of Radiotherapy, Zhejiang Cancer Hospital, Hangzhou, People’s Republic of China
 show all
Pages 4553-4557 | Published online: 14 Sep 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jun Wu, Jing Wang, Qiang Su, Wei Ding, Teng Li, Junxian Yu & Bangwei Cao. (2018) Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis. OncoTargets and Therapy 11, pages 2685-2698.
Read now

Articles from other publishers (5)

Tomoya Takeda, Masanobu Tsubaki, Natsuki Kato, Shuji Genno, Eri Ichimura, Aya Enomoto, Motohiro Imano, Takao Satou & Shozo Nishida. (2021) Sorafenib treatment of metastatic melanoma with c‑Kit aberration reduces tumor growth and promotes survival. Oncology Letters 22:6.
Crossref
Jieshan Guan, Zhijie Luo, Zhiwei Xiao, Yubin Xie & Lizhu Lin. (2019) Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report. BMC Cancer 19:1.
Crossref
Kai Zhou, Jing-wei Zhang, Qi-zhi Wang, Wen-yue Liu, Jia-li Liu, Lan Yao, Ming-min Cai, Sui-ying Ni, Qing-yun Cai, Guang-ji Wang & Fang Zhou. (2018) Apatinib, a selective VEGFR2 inhibitor, improves the delivery of chemotherapeutic agents to tumors by normalizing tumor vessels in LoVo colon cancer xenograft mice. Acta Pharmacologica Sinica 40:4, pages 556-562.
Crossref
Antonio G. Richetta, Virginia Valentini, Federica Marraffa, Giovanni Paolino, Piera Rizzolo, Valentina Silvestri, Veronica Zelli, Anna Carbone, Cinzia Di Mattia, Stefano Calvieri, Pasquale Frascione, Pietro Donati & Laura Ottini. (2018) Metastases risk in thin cutaneous melanoma: prognostic value of clinical-pathologic characteristics and mutation profile. Oncotarget 9:63, pages 32173-32181.
Crossref
. (2017) Apatinib/temozolomide. Reactions Weekly 1676:1, pages 45-45.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.